The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population

OBJECTIVE: Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Reteplase is a fibrin-specific thrombolytic which is used in the treatment of AMI. There is a limited number of studies reporting the postmarketing adverse drug reactions (ADRs) induced by rete...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Res Pharm Pract
Main Authors: Aslanabadi, Naser, Safaie, Naser, Shadfar, Faezeh, Taban-Sadeghi, Mohammad Reza, Feizpour, Hossein, Mashayekhi, Simin Ozar, Hamishehkar, Hadi, Aghdam, Naser Khezerlou, Dousti, Samaneh, Namdar, Hossein, Entezari-Maleki, Taher
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4645133/
https://ncbi.nlm.nih.gov/pubmed/26645027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2279-042X.167049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados